Exogenus Therapeutics
  • About us
    • Our Story
    • Team
    • Partners
    • Funding
      • EXCELLence
      • ExoTalent
      • Exolung
      • Texad
      • Exowound
      • Hexkin
      • Investors
  • Collaborative R&D
  • Technology
    • Umbilical Cord Blood
    • Extracellular Vesicles
    • Pipeline
    • IP & Publications
  • News
  • Careers
  • Contacts
Select Page
Exogenus Therapeutics participates in Cord Blood World Europe 2017

Exogenus Therapeutics participates in Cord Blood World Europe 2017

by admin | May 21, 2017 | News

Joana Correia, Executive Director and Chief Scientific Officer presented last week at Cord Blood World Europe. Under the theme: “Umbilical cord blood supply for the development of Exo-Wound, an exosome-based product for chronic wounds” Joana talked...
Exogenus Therapeutics finalist at 2nd EWMA Wound Care Innovation Symposium

Exogenus Therapeutics finalist at 2nd EWMA Wound Care Innovation Symposium

by admin | May 9, 2017 | News

Exogenus Therapeutics was one of the three finalist projects of the EWMA Alira Health 2nd Wound Care Innovation Symposium that took place on May 4th, at the European Wound Management Association Conference in Amsterdam. Having the opportunity to present its innovative...
Joana Simões Correia selected as a Young Transatlantic Innovation Leader 2017

Joana Simões Correia selected as a Young Transatlantic Innovation Leader 2017

by admin | Apr 5, 2017 | News

It was announced last week that Joana Simões Correia, the Executive Director of Exogenus Therapeutics (Exo-T) is one of the Young Transatlantic Innovation Leaders of 2017. The Young Transatlantic Innovative Leaders Initiative Fellowship is the flagship program of the...
Exogenus Therapeutics winner of the Everis Foundation Award 2016

Exogenus Therapeutics winner of the Everis Foundation Award 2016

by admin | Nov 23, 2016 | News

It was announced today that Exogenus Therapeutics (Exo-T) is the winner of the Everis Foundation Award 2016. The award, which every year distinguishes projects from Industry, Biotechnology & Health, and Digital Economy originating from countries where the Everis...
Exogenus Therapeutics to receive support from Horizon 2020’s SME Instrument Phase 1

Exogenus Therapeutics to receive support from Horizon 2020’s SME Instrument Phase 1

by admin | Oct 24, 2016 | News

Exogenus Therapeutics (Exo-T) is one of the selected SMEs to receive support from the European Commission under the Horizon 2020’s SME Instrument Phase 1. With the SME Instrument, the European Commission aims to support high growth, highly innovative European...
« Older Entries
Next Entries »

VISIT US

Biocant Park
Núcleo 04, Lote 2
3060-197 Cantanhede
Portugal

CONTACT US

+351 231 419 043 (Call to the national fixed network)

team@exogenus-t.com

jobs@exogenus-t.com

QUICK LINKS

Team
Pipeline
Extracellular Vesicles
Privacy Policy

FOLLOW US

  • FollowFollow
  • FollowFollow
  • FollowFollow